2019-11-15T10:32:40-06:00 2018-12-31 MUSCULOSKELETAL TRANSPLANT FOUNDATION 125 MAY ST STE 300 EDISON NJ 08837 990 2018-01-01 223619257 BIOCON INC BIOC 7326610202 125 MAY STREET EDISON NJ 08837 MICHAEL J KAWAS TREASURER/CFO 7326610202 2019-11-14 ASSOCIATE OF FIRM 7326610202 2019-11-15 148.76.171.196 2019-11-15 10:32:40 CS P E8983FB843B4833DCD2BA9F1A88572CCA9AA2E03 E8983FB843B4833DCD2BA9F1A88572CCA9AA2E03 2018 2020-03-31 21:24:44Z JOSEPH A YACCARINO 125 MAY ST EDISON NJ 08837 3469939 false X N/A X 1998 DC BIOCON, INC. (BIO) WAS FORMED TO SERVE AS THE SOLE VOTING MEMBER OF, AND ACT AS THE HOLDING COMPANY FOR, "MUSCULOSKELETAL TRANSPLANT FOUNDATION INC." (MTF) A NON-PROFIT 501(C) ORGANIZATION AND "DEUTSCHES INSTITUT FUR ZELL-UND GEWEBEERSATZ GMBH" (DIZG) A GERMAN NON-PROFIT ORGANIZATION. MTF'S MISSION IS TO PROVIDE QUALITY ALLOGRAFT TISSUES FOR TRANSPLANTATION, RESEARCH AND EDUCATION. DIZG SPECIALIZES IN CULTURING AND DISTRIBUTION OF KERATINOCYTES, MUSCULOSKELETAL, AND OTHER TISSUE FORMS. BIOCON, AS HOLDING COMPANY, HAS AUTHORITY TO APPROVE FUNDAMENTAL AMENDMENTS TO ORGANIZATIONAL DOCUMENTS AND TO APPROVE CERTAIN CORPORATE TRANSACTIONS SUCH AS MERGERS AND DISSOLUTIONS. BIOCON ALSO HAS THE EXCLUSIVE RIGHT TO ELECT OR APPOINT ALL MEMBERS OF THE BOARD OF DIRECTORS OF MTF AND DIZG. BIOCON CONTINUES TO MONITOR AND GUIDE THE ACTIVITIES OF MTF AND DIZG, AS WELL AS ANY AFFILIATES THAT MAY BE FORMED OR ACQUIRED IN THE FUTURE, TO FOSTER THE PROVISION OF HIGH QUALITY HUMAN ALLOGRAFT TISSUE TO THE CO 8 7 0 0 0 3364649 3469939 0 0 3364649 3469939 0 0 0 0 0 3101491 3161133 3101491 3161133 263158 308806 18217477 18191937 17683795 17349449 533682 842488 X BIOCON, INC. (BIO) WAS FORMED TO SERVE AS THE SOLE VOTING MEMBER OF, AND ACT AS THE HOLDING COMPANY FOR, "MUSCULOSKELETAL TRANSPLANT FOUNDATION INC." (MTF) A NON-PROFIT 501(C) ORGANIZATION AND "DEUTSCHES INSTITUT FUR ZELL-UND GEWEBEERSATZ GMBH" (DIZG) A GERMAN NON-PROFIT ORGANIZATION. MTF'S MISSION IS TO PROVIDE QUALITY ALLOGRAFT TISSUES FOR TRANSPLANTATION, RESEARCH AND EDUCATION. DIZG SPECIALIZES IN CULTURING AND DISTRIBUTION OF KERATINOCYTES, MUSCULOSKELETAL, AND OTHER TISSUE FORMS. BIOCON, AS HOLDING COMPANY, HAS AUTHORITY TO APPROVE FUNDAMENTAL AMENDMENTS TO ORGANIZATIONAL DOCUMENTS AND TO APPROVE CERTAIN CORPORATE TRANSACTIONS SUCH AS MERGERS AND DISSOLUTIONS. BIOCON ALSO HAS THE EXCLUSIVE RIGHT TO ELECT OR APPOINT ALL MEMBERS OF THE BOARD OF DIRECTORS OF MTF AND DIZG. BIOCON CONTINUES TO MONITOR AND GUIDE THE ACTIVITIES OF MTF AND DIZG, AS WELL AS ANY AFFILIATES THAT MAY BE FORMED OR ACQUIRED IN THE FUTURE, TO FOSTER THE PROVISION OF HIGH QUALITY HUMAN ALLOGRAFT TISSUE TO THE CO false false 3161133 3469939 BIOCON, INC. (BIO) IS THE SOLE MEMBER OF MAY STREET MEDICAL, LLC. (MSM), OLYPHANT, L.L.C. (OLY) AND JESSUP/PRTB L.L.C. (JESSUP). BIOCON IS ALSO THE SOLE CORPORATE MEMBER OF MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. (MTF) AND SOLE STOCKHOLDER OF THE DEUTSCHES INSTITUT FUR ZELL-UND GEWEBEERSATZ GMBH (DIZG). AS PART OF BIOCON'S MISSION TO SUPPORT MTF, BIOCON SERVES AS THE HOLDING COMPANY FOR THE SEGREGATION, PROTECTION, AND OPERATION OF REAL PROPERTY ASSETS WHICH ARE OCCUPIED BY MTF. FOR INDIVIDUAL STORIES ABOUT DONOR FAMILIES, PLEASE VISIT MTF BIOLOGICS WEBSITE AT HTTPS://WWW.MTFBIOLOGICS.ORG/WHO-WE-SERVE/DONORS- COMMUNITY/DONORS-FAMILIES. STORIES ABOUT RECIPIENTS ARE ALSO AVAILABLE ON THE WEBSITE AT HTTPS://WWW.MTFBIOLOGICS.ORG/WHO-WE-SERVE/DONORS- COMMUNITY/RECIPIENTS AND ON THE YOUTUBE CHANNEL AT HTTPS://WWW.YOUTUBE.COM/USER/THEMTF1. 3161133 true false false false false false false false false false true false false false true true true true false false false false false false false false false false false true false false false false false false false false false false false false true true true true false false true X 8 0 true 0 false true GM false false false false false false false false false false X 8 7 false false false false true false false true true false false true true true true true true true true false NJ X MICHAEL J KAWAS 7326610202 125 MAY STREET EDISON NJ 08837 X WILLIAM W TOMFORD MD CHAIRMAN 2.00 X 0 50000 0 DONALD HACKBARTH MD VICE CHAIRMA 1.00 X 0 24000 0 ALAN MILANAZZO BOD 1.00 X 0 21000 0 DAN M SPENGLER MD BOD 1.00 X 0 15000 0 JOSEPH ZUCKERMAN MD BOD 1.00 X 0 15000 0 JOSEPH A BUCKWALTER MD BOD 1.00 X 0 8000 0 ALLAN GROSS MD BOD 1.00 X 0 8000 0 GERALD FINERMAN MD BOD EMERITUS 1.00 X 0 0 0 VICTOR FRANKEL MD PHD BOD EMERITUS 1.00 X 0 0 0 MARK BOLANDER MD BOD 1.00 X 0 0 0 BRUCE W STROEVER PRESIDENT/CE 60.00 X 0 859507 25758 JOSEPH A YACCARINO PRESIDENT/CE 60.00 X 0 620490 42518 MICHAEL J KAWAS TREASURER/CF 60.00 X 0 588775 43168 JENNIFER BIRMINGHAM SECRETARY/GE 60.00 X 0 421702 43168 2631474 154612 false true false NORTHMARQ CAPITAL SDS 12-0502 MINNEAPOLIS MN 554860502 FINANCING 741315 EDISON TAX COLLECTOR 100 MUNICIPAL BLVD EDISON NJ 08817 GOVERNMENT 392568 AMERICAN LANDSCAPE 586 SOUTH MIDDLEBUSH ROAD SOMERSET NJ 08873 LANDSCAPING 195336 WASTE MANAGEMENT PO BOX 13648 PHILADELPHIA PA 19101 REFUSE REMOVAL 137842 COLLECTOR - TWP OF EDISON 100 MUNICIPAL BLVD EDISON NJ 08817 SEWER 117333 5 125/175 MAY ST., EDISON, NJ 531120 2635169 2635169 1175 MID VALLEY DR., OLYPHANT 531120 524981 524981 1232 MID VALLEY DR.,JESSUP 531120 309789 309789 3469939 3469939 3469939 2645 2645 2464429 2464429 568885 568885 REPAIRS AND MAINTENANCE 124259 124259 CONSULTING FEES 661 661 BANK CHARGES 254 254 3161133 3161133 0 0 3568556 3973134 69234 70624 21710560 7730243 14474967 13980317 104720 167862 18217477 18191937 57718 28281 6534786 6183794 11091291 11137374 17683795 17349449 X 533682 842488 533682 842488 18217477 18191937 308806 X false true X true false X X 1 MUSCULOSKELETAL TRANSPLANT FOUNDATION INC MUSCULOSKELETAL TRANSPLANT FOUNDATION 222803458 10 true 0 0 1 0 true false false false false false false false false false false false false false false true 2899923 2899923 18441633 7502073 10939560 369004 228170 140834 13980317 DUE TO AFFILIATE 11124755 SECURITY DEPOSIT 12619 11137374 X 3469939 3469939 3469939 3161133 3161133 3161133 SCHEDULE D, PAGE 3, PART X BIOCON FOLLOWS GUIDANCE THAT CLARIFIES THE ACCOUNTING FOR UNCERTAINTY IN TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN, INCLUDING ISSUES RELATING TO FINANCIAL STATEMENT RECOGNITION AND MEASUREMENT. THIS GUIDANCE PROVIDES THAT THE TAX EFFECTS FROM AN UNCERTAIN TAX POSITION CAN ONLY BE RECOGNIZED IN THE FINANCIAL STATEMENTS IF THE POSITION IS "MORE- LIKELY-THAN-NOT" TO BE SUSTAINED IF THE POSITION WERE TO BE CHALLENGED BY A TAXING AUTHORITY. THE ASSESSMENT OF THE TAX POSITION IS BASED SOLELY ON THE TECHNICAL MERITS OF THE POSITION, WITHOUT REGARD TO THE LIKELIHOOD THAT THE TAX POSITION MAY BE CHALLENGED. BIOCON HAS PROCESSES PRESENTLY IN PLACE TO ENSURE THE MAINTENANCE OF ITS TAX-EXEMPT STATUS; TO IDENTIFY AND REPORT UNRELATED INCOME; TO DETERMINE ITS FILING AND TAX OBLIGATIONS IN JURISDICTIONS FOR WHICH IT WAS NEXUS; AND TO IDENTIFY AND EVALUATE OTHER MATTERS THAT MAY BE CONSIDERED TAX POSITIONS. BIOCON HAS DETERMINED THAT THERE ARE NO MATERIAL UNCERTAIN TAX POSITIONS THAT REQUIRE RECOGNITION OR DISCLOSURE IN THE FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2018. SCHEDULE D, PAGE 4, PART XIII SCHEDULE D,PART VI, LINE 1E, OTHER: THE AMOUNTS SHOWN ON THE REFERENCED LINE ARE FOR DEPRECIABLE LAND IMPROVEMENTS. true false false false false false false false false BRUCE W STROEVER PRESIDENT/CEO 360153 88780 410574 16500 10919 885265 JOSEPH A YACCARINO PRESIDENT/CEO 474995 129560 15935 16500 29294 663008 MICHAEL J KAWAS TREASURER/CFO 473571 111510 3694 16500 29944 631943 JENNIFER BIRMINGHAM SECRETARY/GEN COUNS 329191 90220 2291 16500 29890 464870 SCHEDULE J, PAGE 1, PART I, LINE 3 BIOCON IS THE SOLE CORPORATE MEMBER OF THE MUSCULOSKELEAL TRANSPLANT FOUNDATION, INC., (MTF). THE BOARD OF DIRECTORS AND OFFICERS OF BIOCON OVERLAPS THAT OF MTF WITH BIOCON HAVING THE EXCLUSIVE RIGHT TO ELECT OR APPOINT ALL MEMBERS OF THE BOARD OF DIRECTORS OF MTF. BELOW IS AN OUTLINE OF MTF'S PROCESS TO ESTABLISH COMPENSATION LEVELS FOR EXECUTIVE AND OFFICER COMPENSATION. EXECUTIVE COMPENSATION REVIEW: EACH YEAR, MTF REVIEWS AND ASSESSES THE REASONABLENESS OF TOTAL COMPENSATION ARRANGEMENTS FOR THE EXECUTIVE TEAM,INCLUDING THE CEO. THE ANALYSIS INCORPORATES COMPENSATION SURVEY DATA FROM 990'S OF COMPANIES OF RELATED INDUSTRIES AND SIMILAR SIZE. A BLEND OF BOTH FOR-PROFIT AND NOT- FOR-PROFIT COMPANIES IS USED. EVERY THIRD YEAR MTF RETAINS THE SERVICES OF AN INDEPENDENT COMPENSATION CONSULTANT TO ASCERTAIN AND DETERMINE THAT MTF IS PAYING AND PROVIDING A REASONABLE TOTAL COMPENSATION PACKAGE TO THEIR EXECUTIVES AND TO PROVIDE AN OPINION LETTER OF THEIR FINDINGS. COMPENSATION COMMITTEE REVIEW: MTF'S BOARD OF DIRECTORS ESTABLISHED A COMPENSATION COMMITTEE IN 1995. THE RESPONSIBILITY OF THE COMMITTEE INCLUDES APPROVAL OF EXECUTIVE AND STAFF COMPENSATION AND CHANGES TO BENEFITS AND REPORTING SUCH APPROVALS TO THE BOARD. THE COMPENSATION COMMITTEE TYPICALLY MEETS SEMI-ANUALLY TO REVIEW MERIT AND BONUS RECOMMENDATIONS. A COPY OF THE COMPENSATION COMMITTEE'S CHARTER, AGENDAS, MEETING MATERIALS, AND MEETING MINUTES ARE MAINTAINED. SCHEDULE J, PAGE 1, PART I, LINE 4 BRUCE W. STROEVER 378,469 0 0 FORM 990 - ORGANIZATION'S MISSION BIOCON, INC. (BIO) WAS FORMED TO SERVE AS THE SOLE VOTING MEMBER OF, AND ACT AS THE HOLDING COMPANY FOR, "MUSCULOSKELETAL TRANSPLANT FOUNDATION INC." (MTF) A NON-PROFIT 501(C) ORGANIZATION AND "DEUTSCHES INSTITUT FUR ZELL-UND GEWEBEERSATZ GMBH" (DIZG) A GERMAN NON-PROFIT ORGANIZATION. MTF'S MISSION IS TO PROVIDE QUALITY ALLOGRAFT TISSUES FOR TRANSPLANTATION, RESEARCH AND EDUCATION. DIZG SPECIALIZES IN CULTURING AND DISTRIBUTION OF KERATINOCYTES, MUSCULOSKELETAL, AND OTHER TISSUE FORMS. BIOCON, AS HOLDING COMPANY, HAS AUTHORITY TO APPROVE FUNDAMENTAL AMENDMENTS TO ORGANIZATIONAL DOCUMENTS AND TO APPROVE CERTAIN CORPORATE TRANSACTIONS SUCH AS MERGERS AND DISSOLUTIONS. BIOCON ALSO HAS THE EXCLUSIVE RIGHT TO ELECT OR APPOINT ALL MEMBERS OF THE BOARD OF DIRECTORS OF MTF AND DIZG. BIOCON CONTINUES TO MONITOR AND GUIDE THE ACTIVITIES OF MTF AND DIZG, AS WELL AS ANY AFFILIATES THAT MAY BE FORMED OR ACQUIRED IN THE FUTURE, TO FOSTER THE PROVISION OF HIGH QUALITY HUMAN ALLOGRAFT TISSUE TO THE COMMUNITY THROUGH THE MOST ECONOMICAL AND EFFICIENT SYSTEM POSSIBLE. FORM 990 FORM 990, PART IV, QUESTIONS 14A AND 14B - BIOCON, INC NOTES THAT IT ANSWERED "NO" TO FORM 990, PART IV, QUESTION 14A AND 14B BECAUSE ITS ONLY INTERNATIONAL ACTIVITY CONSISTS OF DIZG ACTIVITY. 2018 ACTIVITY FOR DIZG IS SUMMARIZED ON FORM 5471. FORM 990, PAGE 2, PART III, LINE 4A BIOCON, INC. (BIO) IS THE SOLE MEMBER OF MAY STREET MEDICAL, LLC. (MSM), OLYPHANT, L.L.C. (OLY) AND JESSUP/PRTB L.L.C. (JESSUP). BIOCON IS ALSO THE SOLE CORPORATE MEMBER OF MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. (MTF) AND SOLE STOCKHOLDER OF THE DEUTSCHES INSTITUT FUR ZELL-UND GEWEBEERSATZ GMBH (DIZG). AS PART OF BIOCON'S MISSION TO SUPPORT MTF, BIOCON SERVES AS THE HOLDING COMPANY FOR THE SEGREGATION, PROTECTION, AND OPERATION OF REAL PROPERTY ASSETS WHICH ARE OCCUPIED BY MTF. FOR INDIVIDUAL STORIES ABOUT DONOR FAMILIES, PLEASE VISIT MTF BIOLOGICS WEBSITE AT HTTPS://WWW.MTFBIOLOGICS.ORG/WHO-WE-SERVE/DONORS- COMMUNITY/DONORS-FAMILIES. STORIES ABOUT RECIPIENTS ARE ALSO AVAILABLE ON THE WEBSITE AT HTTPS://WWW.MTFBIOLOGICS.ORG/WHO-WE-SERVE/DONORS- COMMUNITY/RECIPIENTS AND ON THE YOUTUBE CHANNEL AT HTTPS://WWW.YOUTUBE.COM/USER/THEMTF1. FORM 990, PART V, LINE 4B GERMANY FORM 990, PART VI PART VI, QUESTION 1A - THE BOARD OF DIRECTORS HAS TEN MEMBERS INCLUDING TWO NON-VOTING DIRECTORS EMERITUS. FORM 990, PAGE 6, PART VI, LINE 6 BIOCON, INC.'S ARTICLES OF INCORPORATION AND BY-LAWS SPECIFICALLY PROHIBIT THE EXISTENCE OF MEMBERS/STOCKHOLDERS. INSTEAD, THE COMPANY IS GOVERNED BY ITS BOARD OF DIRECTORS. DIRECTORS SERVE A TERM OF SIX YEARS. HOWEVER, THE BOARD OF DIRECTORS OF BIOCON, INC. OVERLAPS THAT OF THE MUSCULOSKEL- ETAL TRANSPLANT FOUNDATION, INC. WITH ITS VARIOUS MEMBER ORGANIZATIONS. THUS, MTF AND ITS MEMBER ORGANIZATIONS HAVE SOME DEGREE OF INFLUENCE ON BIOCON, INC. FORM 990, PAGE 6, PART VI, LINE 11B MEMBERS OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS WERE PROVIDED WITH A PAPER COPY OF FORM 990. THE 990 WAS REVIEWED AT AN OPEN MEETING OF THE AUDIT COMMITTEE. SUBSEQUENT TO MODIFICATIONS, IF ANY, AS A RESULT OF THE MEETING, THE 990 IS CIRCULATED TO ALL OF THE MEMBERS OF THE BOARD OF DIRECTORS FOR THEIR FINAL REVIEW AND APPROVAL BEFORE FILING. FORM 990, PAGE 6, PART VI, LINE 12C MTF SENDS A COMPREHENSIVE QUESTIONNAIRE ANNUALLY TO BOARD MEMBERS REQUESTING DISCLOSURE OF ANY CONFLICTS OF INTEREST. OFFICERS AND KEY EMPLOYEES ARE EXPECTED TO VOLUNTARILY DISCLOSE ANY CONFLICTS OF INTEREST. FORM 990, PAGE 6, PART VI, LINE 15A THE CEO RECEIVES NO COMPENSATION FOR DUTIES ASSOCIATED WITH BIOCON, INC. AND RELATED DISREGARDED ENTITIES. HE IS PAID BY A RELATED ORGANIZATION CALLED THE MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. FORM 990, PAGE 6, PART VI, LINE 15B THE TREASURER AND SECRETARY RECEIVE NO COMPENSATION FOR DUTIES RELATED TO BIOCON, INC. AND RELATED DISREGARDED ENTITIES. THEY ARE PAID BY A RELATED ORGANIZATION CALLED THE MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. FORM 990, PAGE 6, PART VI, LINE 19 UPON REQUEST, BIOCON, INC., WILL PROVIDE PUBLIC DOCUMENTS THROUGH EMAIL, MAILINGS, AND OFFICE VISITS. FORM 990, PART VII PART VII - BOARD OF DIRECTORS COMPENSATION - THE BOARD OF DIRECTORS RECEIVES NO COMPENSATION FROM BIOCON, INC. FOR ITS ACTIVITIES. THE BOARD MEMBERS ARE PAID HONORARIUMS AND REIMBURSED FOR REASONABLE TRAVEL COSTS ASSOCIATED WITH BOARD MEETINGS BY A RELATED ORGANIZATION - THE MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. MAY STREET MEDICAL LLC 125 MAY STREET EDISON NJ 08837 223751785 SEE PT VII DE 2635169 11910324 BIOCON OLYPHANT LLC 125 MAY STREET EDISON NJ 08837 223619257 SEE PT VII DE 524981 3801110 BIOCON JESSUPPRTB LLC 125MAY STREET EDISON NJ 08837 223619257 SEE PT VII PA 309789 2480503 BIOCON MUSCULOSKELETAL TRANSPLANT FOUNDATION INC 125 MAY STREET EDISON NJ 08837 222803458 CHARITY DC 501C3 10 BIOCON true DEUTSCHES INSTITUT FUR ZELL-UND GEWEBEERSATZ GMBH INNOVATIONSPK WM-V-ARDENE BLDG 42 BERLIN GM SEE PT VII GM BIOCON true DEUTSCHES INSTITUT FUR ZELL-UND GEWEBEERSATZ GMBH INNOVATIONSPK W M-V-ARDN BLDG 42 BERLIN GM SEE PT VII GM BIOCON C CORP true true false false false false false false true false false false false true false false false false true false MUSCULOSKELETAL TRANSPLANT FOUNDATION INC A 524981 ACCTG BOOKS/RECORDS MUSCULOSKELETAL TRANSPLANT FOUNDATION INC A 2633919 ACCTG BOOKS/RECORDS MUSCULOSKELETAL TRANSPLANT FOUNDATION INC H 536130 ACCTG BOOKS/RECORDS MUSCULOSKELETAL TRANSPLANT FOUNDATION INC M 196929 ACCTG BOOKS/RECORDS MUSCULOSKELETAL TRANSPLANT FOUNDATION INC M 269445 ACCTG BOOKS/RECORDS MUSCULOSKELETAL TRANSPLANT FOUNDATION INC R 456054 ACCTG BOOKS/RECORDS MUSCULOSKELETAL TRANSPLANT FOUNDATION INC R 95440 ACCTG BOOKS/RECORDS MUSCULOSKELETAL TRANSPLANT FOUNDATION INC R 382225 ACCTG BOOKS/RECORDS MUSCULOSKELETAL TRANSPLANT FOUNDATION INC A 309789 ACCTG BOOKS/RECORDS MUSCULOSKELETAL TRANSPLANT FOUNDATION INC R 245000 ACCTG BOOKS/RECORDS SCHEDULE R SCHEDULE R RELATED ORGANIZATIONS AND UNRELATED PARTNERSHIPS SCHEDULE R, PART I(B): MAY STREET MEDICAL, LLC. - RENTAL REAL ESTATE OLYPHANT, L.L.C. - RENTAL REAL ESTATE JESSP/PRTB L.L.C. - RENTAL REAL ESTATE SCHEDULE R, PART II(B): MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. - TISSUE BANK DEUTSCHES INSTITUT FUR ZELL-UND GEWEBEERSATZ GMBH - RESEARCH SCHEDULE R, PART IV, LINE 1: DEUTSCHES INSTITUT FUR ZELL-UND GEWEBEERSATZ GMBH - TISSUE BANK DIZG, GMBH HAS BEEN DETERMINED TO HAVE SOME TAX-EXEMPT ACTIVITIES AS WELL AS TAXABLE ACTIVITIES IN GERMANY. THUS, DIZG IS SHOWN AS BOTH AN EXEMPT AND TAXABLE ORGANIZATION ON SCHEDULE R. DIZG IS A BROTHER/SISTER ENTITY RELATIVE TO MTF AND IS WHOLLY OWNED BY BIOCON, INC. SCHEDULE R, PART V, LINE 2, PAGES 1 AND 2: ITEMS (3), (7) AND (8) ARE TRANSACTIONS BETWEEN MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. (MTF) AND DEUTSCHES INSTITUT FUR ZELL-UND GEWEBEERSATZ GMBH (DIZG). THEY DID NOT OCCUR BETWEEN MTF AND BIOCON, BUT ARE INCLUDED BECAUSE DIZG IS WHOLLY OWNED BY BIOCON AND ALSO FOR GREATER TRANSPARENCY. DURING 2018, DIZG REPAID MTF OUTSTANDING ADVANCES TOTALING 382,225. MTF ALSO SOLD TISSUE TO DIZG IN THE AMOUNT OF 536,130. GIVEN THESE CIRCUMSTANCES, NO FORM 926 FILING BY MTF WAS DEEMED NECESSARY.